Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
TrialSpark announced today the formation of High Line Bio following the acquisition of worldwide rights to sprifermin from Merck KGaA, Darmstadt,...
TrialSpark is building a next generation pharma company focused on bringing new treatments to patients faster and more efficiently. Despite the...
TrialSpark announced today that it has raised $156MM in Series C funding. Sam Altman and Lachy Groom led the round, with participation from new and...
TrialSpark Inc., a tech-enabled drug development company dedicated to improving the speed, quality, and innovation of clinical trials, announced a...
In the news release, TrialSpark announces addition of key strategic advisor Steve Holtzman, issued 20-Apr-2021 by TrialSpark over PR Newswire, we are ...
TrialSpark, a tech-enabled drug development partner committed to improving the speed, quality, and innovation of clinical trials, formally announces...
TrialSpark, a tech-enabled drug development partner committed to improving the speed, quality, and innovation of clinical trials, today announced a...
Dr. Michael Mina of the Harvard T. Chan School of Public Health announced today the successful enrollment of the first 500 patients just 10 days...
TrialSpark, a tech-enabled drug development company committed to improving the speed, quality, and innovation of clinical trials, today announced the ...
TrialSpark, a tech-enabled drug development partner committed to improving the speed, quality and innovation of clinical trials, announced today the...
TrialSpark, a tech-enabled drug development partner committed to improving the speed, quality, and innovation of clinical trials, and Limbix, a...
23andMe, the leading consumer genetics company, and TrialSpark, a technology company enabling physician practices to become clinical trial sites, are ...
TrialSpark, a technology company committed to improving the speed, access, and reliability of clinical trials, and Pfizer have entered into a...
TrialSpark, a New York-based technology company that has built a new model for managing and operating clinical trials, today announced the activation ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.